Stay updated on Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded government funding notice and NIH Clinical Center operating status, added new content term “Bone osteosarcoma,” and updated revision version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check24 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page now shows 'Results Submitted' and updates the revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed (minor navigation change).SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as detailed information on various neoplasms and treatments, while removing outdated location terms and drug information.SummaryDifference5%
- Check60 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Cyclophosphamide in Sarcomas Clinical Trial page.